Solís-Mendoza AD, Landa-Saldivar AG, Nájera-Ruiz, ÁS, Villegas-Domínguez JE, Basilio-Ocampo H, Romero-Martínez BS, Flores-Soto E

Language: Spanish
References: 19
Page: 300-310
PDF size: 257.24 Kb.

ABSTRACT

Objective: To determine the factors associated with cognitive decline in older adults who attend the outpatient clinic of the Naval Specialty Hospital of Veracruz. Material and Methods: The study will consist of older adults (aged 60 years or older) who attend the outpatient clinic of the Naval Specialty Hospital of Veracruz, who meet the inclusion criteria. For the cognitive assessment the Montreal Cognitive Assessment (MoCA) will be use, which evaluates six domains: memory, visuospatial ability, executive function, attention, language and orientation, with a maximum score of 30. Results. The relationship between sociodemographic characteristics was analyzed, comorbidities and levels of cognitive decline. Age, female sex, being a widow and people in cohabitation showed moderate cognitive decline. In addition, chronic diseases such as hypertension, obesity, smoking and physical inactivity are associated with the progression of deterioration. Glucose and triglyceride levels are significantly higher in the groups with mild and moderate cognitive impairment compared to the group without impairment. Conclusion: Cognitive impairment is a multifactorial health problem influenced by sociodemographic aspects, the presence of chronic diseases, lifestyle, dietary habits and various metabolic conditions.

REFERENCES

1. Alvarado AM, Salazar ÁM. Análisis del conceptode envejecimiento. Gerokomos 2014; 25(2): 57-62.

2. IMSS. Diagnóstico y Tratamiento del DeterioroCognoscitivo en el Adulto Mayor en el Primer Nivelde Atención. México. 2012.

3. Petersen RC. Mild cognitive impairment. Continuum2016; 22(2): 404-418.

4. González JJ, Santamaría LA, Pedraza OL. Asociaciónde obesidad y dislipidemia con el riesgode progresión a deterioro cognitivo leve y demencia:revisión sistemática. Rev Rep Med Cir2020; 29(2): 93-102.

5. Xu J, Zhang Y, Qiu C, Cheng F. Global and regionaleconomic costs of dementia: a systematicreview. Lancet 2017; 390: S47.

6. Alzheimer’s Association. Alzheimer’s Diseaseand Dementia. 2022. Disponible en:https://www.who.int/es/news-room/factsheets/detail/ageing-and-health

7. Abizanda P, Rodríguez L, Baztán JJ. Tratado demedicina geriátrica: fundamentos de la atenciónsanitaria a los mayores. 2nd Ed. España. Elsevier;2020.

8. Brunier A, Muchnik A. La OMS revela las principalescausas de muerte y discapacidad en elmundo: 2000-2019. OMS 2020.

9. Petersen RC, Lopez O, Armstrong MJ, GetchiusTS, Ganguli M, Gloss D, et al. Practice guidelineupdate summary: Mild cognitive impairment: Reportof the Guideline Development, Dissemination,and Implementation Subcommittee of theAmerican Academy of Neurology. Neurol 2018;90(3): 126.

10. Devanand DP, Goldberg TE, Qian M, RushiaSN, Sneed JR, Andrews HF, et al. Computerizedgames versus crosswords training in mild cognitiveimpairment. NEJM Evid 2020; 1(12): EVIDoa2200121.

11. Hobson J. The montreal cognitive assessment(MoCA). Occup Med 2015; 65(9): 764-765.

12. Dominguez LJ, Veronese N, Vernuccio L, CataneseG, Inzerillo F, Salemi G, et al. Nutrition,Physical Activity, and Other Lifestyle Factors inthe Prevention of Cognitive Decline and Dementia.Nutrients 2021; 13(11): 4080.

13. Ding L, Zhu X, Xiong Z, Yang F, Zhang, X. TheAssociation of Age at Diagnosis of Hypertensionwith Cognitive Decline: the China Health and RetirementLongitudinal Study (CHARLS). J GenIntern Med 2023; 38(6): 1431–1438.

14. Liu YH, Wang YR, Wang QH, Chen Y, Chen X,Li Y, et al. Post-infection cognitive impairmentsin a cohort of elderly patients with COVID-19.Mol Neurodegener 2021; 16: 1-10.

15. Schaich CL, Bancks MP, Hayden KM, Ding J,Rapp SR, Bertoni AG, et al. Visit-to-Visit GlucoseVariability, Cognition, and Global Cognitive Decline:The Multi-Ethnic Study of Atherosclerosis.J Clin Endocrinol Metab 2023; 109(1): e243–e252.

16. Hottman DA, Chernick D, Cheng S, Wang Z, LiL. HDL and cognition in neurodegenerative disorders.Neurobiol Dis 2014; 72 Pt A: 22–36.

17. Li HM, Qiu CS, Du LY, Tang XL, Liao DQ, XiongZY. Causal Association between Circulating Metabolitesand Dementia: A Mendelian RandomizationStudy. Nutrients 2024; 16(17): 2879.

18. Pacholko A, Iadecola C. Hypertension, Neurodegeneration,and Cognitive Decline. Hypertension2024; 81(5): 991–1007.

19. Benito J, Ghosh R, Lapeña J, Martín C, BermejoF. Association between cumulative smoking exposureand cognitive decline in non-dementedolder adults: NEDICES study. Sci Rep 2023;13(1): 5754.